Article
Overview: A New Era of Cancer Genomics in Lymphoid Malignancies.
Oncology - 1 Jan 2015
Iida Shinsuke
Abstract excerpt
Novel technologies including next-generation sequencing have not only delineated the molecular pathogenesis of lymphoid malignancies but also identified novel biomarkers predicting the outcome of specific therapies. In addition, many actionable genetic alterations, which can be targeted by either specific therapeutic compounds or monoclonal antibodies, have been discovered. An appropriate selection of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
